Sofinnova Ventures »

Alkermes shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Alkermes (ALKS) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Alkermes

Tip: Access up to 7 years of quarterly data

All positions including Alkermes held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alkermes by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2023-09-30 $15M 538k 28.01

More positions owned by Sofinnova Ventures

Karuna Therapeutics Ord
Natera (NTRA)
AstraZeneca Sponsored Adr (AZN)
Merck & Co (MRK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Rayzebio
Dex (DXCM)
Aerovate Therapeutics (AVTE)
Intuitive Surgical (ISRG)
Vera Therapeutics Cl A (VERA)
Cytokinetics (CYTK)
Elanco Animal Health (ELAN)
IShares TR Russell 2000 Etf Put Option (IWM)
argenx SE Sponsored Adr (ARGX)
Exelixis Put Option (EXEL)

View all positions for Sofinnova Ventures

Top funds holding Alkermes

BlackRock
Vanguard Group
Wellington Management Company
Pacer Advisors
PRIMECAP Management Company
Bank of New York Mellon
Johnston Asset Management Corp.
Dimensional Fund Advisors
Charles Schwab Investment Management
Artisan Partners Limited Partnership
Norges Bank Investment Management
T. Rowe Price Associates
Goldman Sachs Group
Bank of America Corporation
Westfield Capital Management Company

View all funds holding Alkermes